IRCT20191228045924N1已完成3 期
Evaluation of the efficacy and safety of methylene blue administration for treatment of COVID-19 patients
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 90 years（—）
- 性别
- All
入选标准
- •Confirmed case of Covid-19 (by RT-PCR, HRCT)
- •Admission to intensive care unit
- •Need for intubation and mechanical ventilation (PaO2/FiO2 < 100-200)
- •Written informed consent
排除标准
- •Pregnancy and breastfeeding
- •G6PDH deficiency
- •Severe renal insufficiency (glomerular filtration rate <30 mL/min/1.73m2)
- •Active chronic hepatitis
- •Severe hepatic disease defined by GOT or GPT levels three times above the normal upper limit
- •Patients with history of allergic reaction or significant sensitivity to methylene blue
- •Treatment with immunosuppressive agents
- •Use of other investigational drugs in the moment of inclusion
研究者
相似试验
已完成
4 期
A clinical trial to compare the effect of methylphenidate and atomoxetine in children with attention deficit hyperactivity disorderCTRI/2011/08/001981Department of Psychiatry69
招募中
3 期
Evaluation of the efficacy and safety of methylprednisolone pulse therapy in treatment of Covid-19 patients with Acute respiratory distress syndromeIRCT20200406046963N1Artesh University of Medical Sciences40
已完成
4 期
A clinical trial to study the effects of two drugs, Metformin Immediate Release and Metformin Extended Release in newly diagnosed type 2 diabetes mellitus patients.CTRI/2021/04/033194Bangalore Medical College and Research Institute70
进行中（未招募）
不适用
To evaluate the effectiveness of MetaDerm Cream in Atopic DermatitisCTRI/2017/06/008950Haus Bioceuticals Inc
进行中（未招募）
1 期
Etude d’efficacité et d’acceptabilité du méthylphénidate dans les troubles de la marche de la maladie de Parkinson : Etude multicentrique en double aveugle versus placebo. - PARGKAIT IIEUCTR2008-005801-20-FRCentre Hospitalier Régional et Universitaire de Lille69